Santé log5d
Black Diamond Therapeutics to Host Webcast Presentation of Initial Phase 2 BDTX-1535 Data in Patients With Recurrent EGFRm NSCLC
Webcast to be held Monday, September 23, at 8:00 a.m. ET ...
Santé log7d
Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements
Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress” or “Company”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through ...
Santé log7d
Apellis Receives Negative CHMP Opinion for Pegcetacoplan for Geographic Atrophy (GA) in the EU Following Re-Examination
“We have seen the profound impact this medicine has had for GA patients in the U.S. and remain committed to expanding access to this crucial treatment, focusing on serving unmet patient needs in the U ...
Santé log8d
Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults
(NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced ...
Santé log7d
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Eosinophilic Esophagitis (EoE) in Children as Young as 1 Year Old
(NASDAQ: REGN) and Sanofi today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the expanded approval of ...
Santé log8d
Bavarian Nordic Receives EMA Approval of Mpox Vaccine for Adolescents
MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMA; Represents the second EMA approval of an MVA-BN-based vaccine ...
Santé log8d
Leap Distributors Acquires Leap Surgical and DUB Enterprises: Partnership Positions Company for Continued Growth
We’re thrilled to unite the strengths of DUB Enterprises and Leap Surgical into a single, powerful entity. This acquisition enables us to provide top-tier service and access to high-quality medical ...
Santé log7d
Ipsen’s Iqirvo® (elafibranor) approved in the European Union as first new treatment for primary biliary cholangitis in nearly a decade
This new European approval reinforces Ipsen’s commitment to advancing medical innovations to treat people living with rare cholestatic liver diseases ...
Santé log7d
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
Pending authorization of the Omicron KP.2-adapted vaccine by the EC, both the Omicron KP.2-adapted vaccine and the Omicron JN.1-adapted vaccine will be available across the EU, though availability ...
Santé log7d
Novo Nordisk A/S: Monlunabant phase 2a trial in obesity successfully completed
Novo Nordisk today announced headline results from a phase 2a clinical trial with monlunabant, a small molecule oral cannabinoid receptor 1 (CB1) inverse agonist. Monlunabant, formerly INV-202, was ...
Santé log8d
Safety Shot Partners with Launchpad to Tap into the Large and Influential College Student Market
As part of the Safety Shot partnership, ATR will leverage peer-to-peer marketing, product trials, and will engage in ambassador-led activities on campuses and on social media. Ambassadors will ...
Santé log9h
Lyra Therapeutics to Present Study Results for LYR-210 and LYR-220 in Two Presentations at the ARS and AAO-HNS Annual Meetings
Poster Presentation American Rhinologic Society (ARS) 2024 Annual Meeting Title: Efficacy and safety of LYR-210 for CRS from the pivotal Phase 3 ENLIGHTEN 1 trial Presenting Author: Vineeta Belanger, ...